JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v8i5.7289ArticleHome-Nebulized Inhaled Glucocorticoid Therapy in Pediatric Respiratory Diseaseshttps://artdesignp.com/journal/JCNR/8/5/10.26689/jcnr.v8i5.7289DongJiuwei,ZhangLili,JiangXiaohua2024852024-06-20Objective: To evaluate the therapeutic effect of home-nebulized inhaled glucocorticoid therapy in pediatric respiratory diseases. Methods: 60 cases of children with respiratory diseases admitted between October 2022 and October 2023 were selected as study subjects and randomly divided into the control group and the observation group, 30 cases each. The control group was provided with conventional treatment only, while the observation group was provided with home-nebulized inhalation glucocorticosteroid treatment, and the treatment effects, clinical symptom relief time, disease recurrence rate, and treatment satisfaction of the children’s families were recorded and compared between the two groups. Results: A comparison of the two groups in terms of gender and age showed that the differences were not statistically significant (P > 0.05). In terms of clinical efficacy, the total effective rate of the observation group was 90.00%, which was significantly higher than that of the control group of 66.67% (P < 0.05). Compared with the control group, the disappearance time of the clinical symptoms of the observed group was significantly shortened (P < 0.05). In addition, the satisfaction scores of the families of the children in the observation group were significantly higher than those of the control group (P < 0.05). Conclusion: Home-nebulized inhalation glucocorticoid therapy shows significant clinical efficacy in pediatric respiratory diseases, significantly reduces the time of disappearance of clinical symptoms, and improves the satisfaction of patients’ families, which provides an effective treatment option for children.

Dai X, 2017, Application of Home-Nebulized Inhaled Glucocorticoid Therapy in Pediatric Respiratory Diseases. Electronic Journal of Clinical Medicine Literature, 4(12): 2317–2318.

Hao C, 2021, Analysis of the Use of Nebulizing Inhalers in the Treatment of Pediatric Respiratory Diseases. China Medical Device Information, 27(16): 78–79.

Sowerby LJ, Patel KB, Schmerk C, et al., Effect of Low Salicylate Diet on Clinical and Inflammatory Markers in Patients with Aspirin-Exacerbated Respiratory Disease – A Randomized Crossover Trial. J Otolaryngol Head Neck Surg, 50(1): 27. https://doi.org/10.1186/s40463-021-00502-4

Xie Y, 2020, Application of Home-Nebulized Inhaled Glucocorticoid Therapy in Pediatric Respiratory Diseases. Oriental Medicine, 2020(12): 106.

Rosenberg T, Philipsen BB, Mehlum CS, et al., 2019, Therapeutic Use of the Human Papillomavirus Vaccine on Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-Analysis. J Infect Dis, 219(7): 1016–1025.

Wang JF, 2020, Home-Nebulized Inhaled Glucocorticoid Therapy in Pediatric Respiratory Diseases. Family Medicine Medical Selection, 2020(10): 370.

Alrahmany D, Ghazi IM, 2021, Cytokine Storm is the Cryptic Killer Behind Coronavirus Disease-2019 Infections, Review of the Current Evidence to Identify Therapeutic Options. Reviews in Medical Microbiology, 32(1): 57–65. https://doi.org/10.1097/MRM.0000000000000242

Shen HX, 2016, Home-Nebulized Inhaled Glucocorticoid Therapy in Pediatric Respiratory Diseases. Journal of Clinical Pediatrics, 29(11): 106.

Wang L-Z, 2016, Application Value of Home-Nebulized Inhaled Glucocorticoids in the Treatment of Pediatric Respiratory Diseases. Electronic Journal of Clinical Medicine Literature, 3(35): 6919–6920.

Zhang Y, Li Y, Wang Y, 2020, Application Effect of Home-Nebulized Inhaled Glucocorticoids in the Treatment of Pediatric Respiratory Diseases. China Medical Guide, 18(12): 121–122.